Research Proof & Publications

50+ peer-reviewed publications across academic, biotech, and pharmaceutical research.

Selected Publications

A representative selection from 50+ peer-reviewed publications.

  • 2026

    Network pharmacology and molecular docking reveal mechanisms of drug resistance in taxane-resistant cancer cells via C9 pathway modulation

    Journal
    Journal of Translational Medicine

  • 2026

    Integrated multi-omics analysis identifies novel biomarkers for treatment response in triple-negative breast cancer

    Journal
    Molecular Cancer Research

  • 2026

    Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: a PRISMA 2020 systematic review and meta-analysis

    Journal
    ESMO Open